A DNA test could help match patients with psychiatric medications, potentially reducing the long and frustrating trial-and-error process.

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...

Genomind, a leader in precision medicine and pharmacogenomic (PGx) testing, today announced it has been awarded a contract to support the Defense Health Agency’s (DHA) Research & Engineering (R&E) ...

Lee Zeldin, the E.P.A. administrator, revived a plan created during the first Trump administration to end the testing of chemicals on mammals. By Lisa Friedman The Environmental Protection Agency will ...

"We've halted many years ago, but with others doing testing I think it's appropriate to do so," the president told reporters aboard Air Force One. Experts say that the resumption of testing would be a ...

GYEONGJU, South Korea — President Donald Trump said Wednesday he had instructed the Defense Department to “immediately” start testing nuclear weapons "on an equal basis" with other nations. “Because ...

GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...